Structure–activity relationships and CoMFA of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic properties
Authors:
- Ronald PalinRPRonald Palin
- John K. ClarkJCJohn K. Clark
- Louise EvansLELouise Evans
- Andrea K. HoughtonAHAndrea K. Houghton
- Philip S. JonesPJPhilip S. Jones
- Alan ProsserAPAlan Prosser
- Grant WishartGWGrant Wishart
- Kazuya YoshiizumiKYKazuya Yoshiizumi
- 1 March 2008
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 16 (6) , 2829-2851
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Synthesis and evaluation of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic and sedative propertiesBioorganic & Medicinal Chemistry, 2006
- Synthesis and SAR studies of 3-phenoxypropyl piperidine analogues as ORL1 (NOP) receptor agonistsBioorganic & Medicinal Chemistry Letters, 2005
- 4-Bromomethyl-2-chlorooxazole––a versatile oxazole cross-coupling unit for the synthesis of 2,4-disubstituted oxazolesTetrahedron Letters, 2004
- MIMIC: A molecular-field matching program. Exploiting applicability of molecular similarity approachesJournal of Computational Chemistry, 1997
- cDNA Cloning of an orphan opiate receptor gene family member and its splice variantFEBS Letters, 1994
- Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene familyFEBS Letters, 1994
- cDNA cloning and regional distribution of a novel member of the opioid receptor familyFEBS Letters, 1994
- ORL1, a novel member of the opioid receptor familyFEBS Letters, 1994
- The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and catsPain, 1977
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973